Biochemical Makers of Cardiac Disease
Biochemical Makers of Cardiac Disease
Biochemical Makers of Cardiac Disease
CARDIAC DISEASE
Learning Objectives
What are Cardiac Markers
Enumerate different cardiac markers
Importance/Role of different biochemical markers
in the diagnosis of Acute MI
Cardiac Marker
A cardiac marker is a clinical labaratory test
useful in detection of AMI or a minor
myocardial injury.
ACUTE MYOCARDIAL
INFARCTION
Clinical history
Evolutionary changes in ECG
Initial ECG : Positive in 50% of AMI cases
Serial tracings : Sensitivity is above 75%
Abnormal cardiac enzymes/ proteins
WHO Criteria : Two out of three positive for
diagnosis of AMI
CLINICAL HISTORY
Chest Pain
Its character? tight", "heavy", "constricting"
Its location? typically retrosternal,
Its duration? "prolonged", i.e. at least 20 minutes,
and usually much longer.
BIOMARKERS OF CARDIAC INJURY
Cardiac Enzymes
Creatine Kinase (CK)
Lactate dehydrogenase(LD)
Aspartate aminotransferase(AST)
Cardiac Proteins
Troponin-I, Troponin-T
Myoglobin
Serum Creatine Kinase (CK)
(Reference Range: 25 - 192 U/L)
Plasma CK activity
97% by CK-MM
<3% by CK-MB
Starts to rise 3-8 hrs post chest pain
Peak 12-24 hrs
return to normal 3-4 days
not specific
CK-MB (CK-2)
• Sampling
Sensitivity <50% if one sample is taken
Sensitivity >98% if serial sampling at 0, 6h,12h, 24 h
Specificity 100%
• Other causes of raised plasma activity of CK-MB
Cardiac procedures
Crush syndrome
Major surgery
Rhabdomyolysis
Severe exercise
AST(Aspartate Aminotransferase)
LD Isoenzyme 1 2 3 4 5
Liver - - - + ++
Skeletal muscle - - - + ++
MI : Flipping (LD1 to LD2 >1)
Cardiac Proteins
• Serum Myoglobin
• Cardiac Troponin T (cTnT)
• Cardiac Troponin I (cTnI)
Serum Myoglobin
tropomysin strand
Troponin-I: inhibits contraction in the resting state.
Troponin-T:
• increased 3-8 hr post chest pain
• peak 1- 4 days
• increased for up to 14 days
Troponin-I:
• increased 3-8 hr post chest pain
• peak 1-2 days
• returns to normal 5days
• More specific & sensitive as compared to cTnT
Both specific for myocardium
Brain Natriuretic Peptide (BNP)
• Synthesized in myocardium
• Associated with poor prognosis
• Have potential to complement standard cardiac
markers
• Requires versatile and applicable analytical assays
Emerging Cardiac Risk Factors